Library / Laws / 113th Congress / House Bills / H.R. 3709
H.R. 3709
To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2013-12-11 | 6.1K | ⠃⠗⠋ |